Rocket Pharmaceuticals, Inc. Appoints Aaron Ondrey as Chief Financial Officer
Position
Chief Financial Officer
Company
Rocket Pharmaceuticals
Description
Rocket Pharmaceuticals, Inc. announced the appointment of Aaron Ondrey as Chief Financial Officer, bringing more than 20 years of experience in financial management, strategic planning, commercial finance, capital allocation, and mergers and acquisitions.
Quick answer
Rocket Pharmaceuticals, Inc. Appoints Aaron Ondrey as Chief Financial Officer (March 26, 2024). Rocket Pharmaceuticals is based in New York, New York, United States.
- Who is the new Chief Financial Officer at Rocket Pharmaceuticals?
- Rocket Pharmaceuticals named Aaron Ondrey Chief Financial Officer, announced March 26, 2024.
- What did Rocket Pharmaceuticals announce on March 26, 2024?
- Rocket Pharmaceuticals, Inc. announced the appointment of Aaron Ondrey as Chief Financial Officer, bringing more than 20 years of experience in financial management, strategic planning, commercial finance, capital allocation, and mergers and acquisitions.
- What does Rocket Pharmaceuticals do?
- Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company seeking gene therapy cures.
- Where is Rocket Pharmaceuticals based?
- Rocket Pharmaceuticals is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- VolitionRx (March 19, 2024), BioMarin Pharmaceutical (March 8, 2024), Elevation Oncology (March 4, 2024) and Precision BioSciences (February 13, 2024) also announced leadership changes within 45 days of Rocket Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- VolitionRx Limited Appoints Dr Andrew Retter as Chief Medical Officer (March 19, 2024)
- BioMarin Appoints Cristin Hubbard as Chief Commercial Officer (March 8, 2024)
- Elevation Oncology Appoints Julie Cherrington as Chief Executive Officer and Alan Sandler as Chief Medical Officer (March 4, 2024)
- Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations (February 13, 2024)
- Bicara Therapeutics Appoints Jeltje Schulten as SVP of Clinical and Medical Affairs and Rita Dalal as Vice President of Clinical Development (March 26, 2024)
- IDRx Appoints Dr. David P. Kerstein as Chief Medical Officer (March 27, 2024)
Who to call at Rocket Pharmaceuticals, and when
A new leader at Rocket Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Rocket Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rocket Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rocket Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rocket Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Rocket Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.